Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

NCT00089193 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: incomplete Freund's adjuvant
BIOLOGICAL: multi-epitope melanoma peptide vaccine
BIOLOGICAL: sargramostim

Sponsor

Craig L Slingluff, Jr

Collaborators

[object Object]